An analysis from the law firm Spencer Fane found that 340B refunds have been concentrated among certain manufacturers and drugs.

Manufacturer Refunds to 340B Providers Have Steadily Increased Since 2019, Says Analysis

A recent analysis of the increasing annual total number of drug manufacturer refunds to 340B covered entities notes they are [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at